Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by Dude51on Apr 08, 2021 6:41pm

160 Views

Post# 32963902

Nice try Analonomoose

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:59:42	A	0.045	0.005	4,000	33 Canaccord	1 Anonymous	K
15:59:42	A	0.045	0.005	15,000	33 Canaccord	1 Anonymous	K
15:59:42	A	0.045	0.005	41,000	33 Canaccord	1 Anonymous	K
15:59:42	A	0.045	0.005	30,000	1 Anonymous	1 Anonymous	K
15:59:39	A	0.045	0.005	29,000	1 Anonymous	1 Anonymous	K
15:59:39	A	0.045	0.005	1,000	1 Anonymous	1 Anonymous	K
15:57:51	P	0.045	0.005	100	19 Desjardins	7 TD Sec	E
15:54:13	A	0.045	0.005	20,000	85 Scotia	1 Anonymous	K
15:49:28	V	0.045	0.005	40,000	79 CIBC	1 Anonymous	K
15:49:27	M	0.045	0.005	500	79 CIBC	7 TD Sec	E